Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Black Garlic North America is a specialized food technology and nutraceutical company focused on the production of fermented black garlic. The company employs a proprietary, long-term aging process involving controlled heat and humidity to transform raw garlic into a nutrient-dense functional food. This process significantly enhances the levels of S-allyl-cysteine (SAC), a potent antioxidant and bioactive compound associated with cardiovascular and immune health. Their product portfolio includes retail-ready whole bulbs and cloves, as well as industrial-grade purees and powders for use in the supplement and food manufacturing industries. Based in Hillsboro, Wisconsin, the company adheres to clean-label standards, producing non-GMO and preservative-free products. Black Garlic North America serves as both a direct-to-consumer brand and a bulk supplier for the broader health and wellness market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Black Garlic North America.